HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick Byanyima Selected Research

Patrick Byanyima Research Topics

Disease

7Tuberculosis (Tuberculoses)
01/2022 - 10/2016
2Pneumonia (Pneumonitis)
01/2019 - 01/2017
1Obstructive Lung Diseases (Obstructive Lung Disease)
01/2019
1HIV Infections (HIV Infection)
01/2019
1Acquired Immunodeficiency Syndrome (AIDS)
12/2018
1Opportunistic Infections (Opportunistic Infection)
09/2018
1Virus Diseases (Viral Diseases)
01/2017
1Hypoxia (Hypoxemia)
10/2016
1Pulmonary Tuberculosis
10/2016
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2012

Drug/Important Bio-Agent (IBA)

2C-Reactive ProteinIBA
12/2020 - 01/2019
1RNA (Ribonucleic Acid)IBA
01/2022
1Pharmaceutical PreparationsIBA
10/2021
1telomerase RNA (bTR)IBA
10/2019
1fibrin fragment D (D-dimer)IBA
01/2019
1Fibrinogen (Factor I)FDA Link
01/2019
1Hyaluronic Acid (Hyaluronan)IBA
01/2019
1Interferon-gamma (Interferon, gamma)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2019
1Lipopolysaccharide ReceptorsIBA
01/2019
1Fatty Acid-Binding ProteinsIBA
01/2019
1Oxygen (Dioxygen)IBA
12/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2017
1MucinsIBA
01/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1Interleukin-10 (Interleukin 10)IBA
10/2016
1Carbon MonoxideIBA
10/2016
1AcidsIBA
10/2016
1Dihydropteroate Synthase (Dihydropteroate Synthetase)IBA
01/2012

Therapy/Procedure

2Therapeutics
12/2018 - 01/2018
1Contraindications
01/2022
1Art Therapy
09/2018